Akèy › Maladi ren kwonik
Etid klinik pou Maladi ren kwonik ap rekrite nan Etazini
118 etid pou Maladi ren kwonik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY16 etid
- Houston, TX15 etid
- Boston, MA15 etid
- Dallas, TX15 etid
- Philadelphia, PA15 etid
- Chicago, IL13 etid
- Orlando, FL11 etid
- Atlanta, GA10 etid
- Durham, NC9 etid
- Kansas City, MO9 etid
- Albuquerque, NM8 etid
- San Antonio, TX8 etid
- Washington, DC8 etid
- Cincinnati, OH7 etid
- Miami, FL7 etid
- Ann Arbor, MI7 etid
- Los Angeles, CA7 etid
- Baltimore, MD7 etid
- Aurora, CO6 etid
- Nashville, TN6 etid
- Pittsburgh, PA6 etid
- Salt Lake City, UT6 etid
- St. Louis, MO6 etid
- The Bronx, NY6 etid
- Cedar Rapids, IA5 etid
- Memphis, TN5 etid
- Brick, NJ5 etid
- Birmingham, AL5 etid
- Charlotte, NC5 etid
- Mountain View, CA5 etid
- Indianapolis, IN5 etid
- Hollywood, FL5 etid
- New Haven, CT5 etid
- Santa Monica, CA5 etid
- Queens, NY5 etid
- Phoenix, AZ5 etid
- Cleveland, OH5 etid
- Seattle, WA5 etid
- Jacksonville, FL5 etid
- Columbia, SC4 etid
Pa eta
- Alabama11 etid
- Arizona9 etid
- Arkansas3 etid
- Colorado12 etid
- Connecticut8 etid
- Distrik Columbia5 etid
- Florid23 etid
- Georgia16 etid
- Illinois18 etid
- Indiana7 etid
- Iowa5 etid
- Kalifòni22 etid
- Kentucky4 etid
- Lwizyàn4 etid
- Maryland11 etid
- Massachusetts17 etid
- Michigan13 etid
- Minnesota11 etid
- Mississippi5 etid
- Missouri16 etid
- Nebraska3 etid
- Nevada4 etid
- New Jersey9 etid
- New Mexico9 etid
- New York26 etid
- North Carolina18 etid
- Ohio15 etid
- Oregon4 etid
- Pennsylvania21 etid
- South Carolina8 etid
- Tennessee14 etid
- Texas25 etid
- Utah7 etid
- Virginia6 etid
- Washington5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Immune System Related Kidney Disease
Ap rekriteEtid obsèvasyon
Laj 10 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001979An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT05106387A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 24, 2026 · NCT07624305Concomitant Renal and Urinary Bladder Allograft Transplantation
Ap rekriteFaz 1 bonè
Laj 1 a 60 · Tout sèks · Mizajou Sep 24, 2026 · NCT04626167CommunityRx-Kidney Health
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07237295Lifestyle Intervention In CKD
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07633145Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Ap rekriteFaz 3
Laj 2 a 18 · Tout sèks · Mizajou Sep 21, 2026 · NCT07498335Improving the Collaborative Health of Adult Dyads
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05370014A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 16, 2026 · NCT07107945A Natural History Study of Metabolic Sizing in Health and Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 99 · Tout sèks · Mizajou Sep 15, 2026 · NCT05398783Partners Calciphylaxis Biobank
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03032835Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Ap rekriteFaz 1/2
Laj 40 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT07224763A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07753993Feasibility of The Health Integrated Nutrition and Kidney Wellness Program
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07518719Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05655325Improving Coronary Vascular Health in Women
Ap rekriteFaz 2
Laj 45 a 75 · Fanm · Mizajou Sep 8, 2026 · NCT06843902Pivotal Study of the Velocity™ pAVF System
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939A Long-Term Follow-Up Study of Participants Exposed to REACT
Ap rekriteEtid obsèvasyon
Laj 30 a 80 · Tout sèks · Mizajou Sep 1, 2026 · NCT05918523Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Ap rekrite
Laj 65 a 100 · Tout sèks · Mizajou Aug 26, 2026 · NCT06738394Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06978127Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Ap rekriteFaz 4
Laj 19 a 90 · Tout sèks · Mizajou Aug 21, 2026 · NCT06110130Breakthrough - T1DM and Chronic Kidney Disease
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Aug 20, 2026 · NCT07592000Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.